Milrinone vs Dobutamine for the Management of Cardiogenic Shock-Reference-Cited by-同舟云学术

Milrinone vs Dobutamine for the Management of Cardiogenic Shock

Published:2023-07 Issue:5 Volume:2 Page:100393
ISSN:2772-963X
Container-title:JACC: Advances
language:en
Short-container-title:JACC: Advances

Author:

Di Santo Pietro,Dehghan Kooroush,Mao Brennan,Jung Richard G.,Fadare Daniel,Paydar John,Parlow Simon^ORCID,Motazedian Pouya,Prosperi-Porta Graeme^ORCID,Abdel-Razek Omar,Joseph Joanne,Goh Cheng Yee,Chung Kevin,Mulloy Andrew,Ramirez F. Daniel,Simard Trevor,Hibbert Benjamin,Mathew Rebecca,Russo Juan J.

Publisher

Elsevier BV

Reference21 articles.

1. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association;van Diepen;Circulation,2017

2. Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction;Koreny;Am J Med,2002

3. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission;Marenzi;Crit Care Med,2010

4. Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality;Tarvasmaki;Eur J Heart Fail,2018

5. Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study;Lauridsen;Crit Care,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The persistent poor prognosis in cardiogenic shock: Insights from recent trials;European Journal of Heart Failure;2024-09-09

2. Trials and Tribulations of Inotrope Choice in Cardiogenic Shock With Renal Dysfunction;JACC: Advances;2023-07